Glaxosmithkline | 当期純利益





当期純利益 変化する 日付
AbbVie USD 1.82B 1.63B 2025-12
Amgen USD 1.33B 1.88B 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Aurora Cannabis CAD -51.47M 36.26M 2025-09
Bausch Health Companies USD -112M 291M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Canopy Growth CAD -1.64M 39.89M 2025-09
Corcept Therapeutics USD 24.29M 4.62M 2025-12
Drreddys Laboratories INR 12.1B 2.08B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Glaxosmithkline GBP 2.71B 1.27B 2025-09
J&J USD 5.12B 36M 2025-12
Merck USD 2.96B 2.82B 2025-12
Novartis USD 3.93B 96M 2025-09
Pacira USD 5.43M 10.28M 2025-09
Perrigo USD 7.5M 15.9M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
Phibro Animal Health USD 3.18M 3.79M 2024-12
Prestige Brands USD 46.7M 22.44M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
Takeda JPY 103.64B 115.44B 2025-12
Teva Pharmaceutical Industries USD 480M 47M 2025-12
Zoetis USD 603M 118M 2025-12


Glaxosmithkline 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.